Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated April 27, 2021, serves as a report of a foreign private issuer. The filing announces the scheduling of Cellectis S.A.'s Combined Ordinary and Extraordinary General Meeting.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus prior periods are reported in this filing. The primary operational change noted is the format of the upcoming shareholder meeting due to the COVID-19 pandemic.
Guidance, Outlook, and Management Commentary
- Meeting Details: The Combined Ordinary and Extraordinary General Meeting is scheduled for June 1, 2021, at 2:30 p.m. Paris time.
- Location: 8, rue de la Croix Jarry, 4th floor, 75013 Paris, France.
- Attendance Restrictions: In accordance with French Ordinance No. 2020-321 (extended by Decree no. 2021-255), the meeting will be held in closed session without physical presence of shareholders.
- Voting: Shareholders may be represented and vote under conditions specified in the attached Notice of Combined Shareholders' Meeting.
- Exhibits: Exhibit 99.1 contains the Notice of Combined Shareholders' Meeting including the Text of Resolutions.
Key Facts for Investor Verification
- Verify the specific resolutions to be voted on in the attached Exhibit 99.1.
- Confirm the proxy voting procedures and deadlines for the June 1, 2021 meeting.
- Review the Company's Form 20-F for the most recent financial performance data, as this filing contains none.